Skip to main content
Sinopharm Tech Holdings Limited logo

Sinopharm Tech Holdings Limited — Investor Relations & Filings

Ticker · 8156 ISIN · KYG2159V1418 HKEX Wholesale and retail trade
Open in API
Filings indexed 1,471 across all filing types
Latest filing 2020-10-08 Share Issue/Capital Cha…
Country HK Hong Kong
Listing HKEX 8156

About Sinopharm Tech Holdings Limited

http://www.sinopharmtech.com.hk

Sinopharm Tech Holdings Limited is an investment holding company primarily engaged in the big health industry and pharmaceutical supply chain business. The company focuses on the trading and distribution of medical and related products, including Chinese patent medicines and health products, targeting the market in the PRC. It develops its supply chain operations using "Internet Plus" services, leveraging technology to provide value-added services to industry operators and product suppliers. The Group is also integrating AI analytics to enhance its operations within the healthcare sector.

Recent filings

Filing Released Lang Actions
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 SEPTEMBER 2020
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' and is addressed to the Hong Kong Exchanges and Clearing Limited. It details movements in authorized share capital, issued share capital, share options, warrants, convertibles, and other share-related activities for the month ended 30/09/2020. The content focuses on share capital changes, share options, warrants, and convertible bonds, with no financial performance data, earnings, or management discussion. This type of document is a regulatory filing reporting share capital movements and related securities information to the exchange. It is not an annual or interim report, earnings release, or management report. It is also not a proxy, voting result, or remuneration report. Given the detailed share capital movement data and the nature of the filing, the most appropriate classification is 'Share Issue/Capital Change' (SHA). The document length and detail confirm it is the report itself, not just an announcement or certification.
2020-10-08 English
FURTHER EXTENSION OF LONG STOP DATE OF THE CONNECTED TRANSACTION INVOLVING ALLOTMENT AND ISSUE OF NEW SHARES UNDER SPECIFIC MANDATE
Capital/Financing Update Classification · 95% confidence The document is an announcement from Sinopharm Tech Holdings Limited regarding a further extension of the long stop date for a connected transaction involving the allotment and issue of new shares under a specific mandate. It references previous announcements and supplemental agreements extending the deadline for completion of the transaction. The content focuses on updates to the timeline of a financing-related transaction rather than presenting financial results, management discussion, or regulatory certifications. The document length is 4020 characters, which is relatively short and typical for an announcement rather than a full report. The subject matter relates to capital structure changes and financing activities. Therefore, the document fits best under the category of Capital/Financing Update (CAP).
2020-10-05 English
ANNUAL REPORT 2020
Annual Report Classification · 100% confidence The document is titled 'ANNUAL REPORT' for Sinopharm Tech Holdings Limited and includes detailed sections typical of an annual report such as Chairperson's Statement, CEO's Statement, Management Discussion and Analysis, Corporate Governance Report, Directors' Report, Environmental, Social and Governance Report, Independent Auditor's Report, and full consolidated financial statements. The document length is substantial (15,000 characters) and contains comprehensive financial and operational information for the fiscal year 2020. It is not a brief announcement or a certification letter but a full report covering company activity and financial performance for the year. Therefore, it fits the definition of an Annual Report (10-K). FY 2020
2020-09-29 English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 30 JUNE 2020
Annual Report Classification · 95% confidence The document is titled 'ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 30 JUNE 2020' and contains detailed audited consolidated financial statements including profit or loss, comprehensive income, financial position, and notes to the consolidated financial statements. It covers the full fiscal year ended 30 June 2020 and includes extensive financial data and analysis. The document is about 15,000 characters long, indicating it is a full report rather than a brief announcement. The content matches the characteristics of an Annual Report, which provides a comprehensive overview of company activity and full financial performance for the year. Therefore, the document should be classified as an Annual Report (10-K). FY 2020
2020-09-29 English
SUPPLEMENTAL INFORMATION IN RELATION TO PROFIT WARNING
Regulatory Filings Classification · 95% confidence The document is an announcement by Sinopharm Tech Holdings Limited regarding a profit warning update. It references preliminary unaudited consolidated management accounts for the year ended 30 June 2020 and indicates that the final annual results will be published later. The document is relatively short (4347 characters) and serves to inform shareholders and potential investors about expected financial performance before the official annual results release. It does not contain full financial statements or detailed financial analysis itself, but rather is a supplemental announcement related to a profit warning. This fits the profile of a Regulatory Filing (RNS) as it is a regulatory announcement providing material information but not the full annual report or financial statements.
2020-09-22 English
CHANGE OF HEAD OFFICE AND PRINCIPAL PLACE OF BUSINESS IN HONG KONG
Board/Management Information Classification · 95% confidence The document is an announcement from Sinopharm Tech Holdings Limited regarding a change of the company's head office and principal place of business in Hong Kong. It is a formal notification about a change in company details, specifically the office location, and includes information about the board of directors. There is no financial data, no mention of financial results, no audit information, no voting results, no legal proceedings, no capital changes, and no other report content. The document is short (2362 characters) and serves as a regulatory announcement about company information. According to the filing definitions and rules, announcements about changes in company details such as office address and board composition fall under Board/Management Information (MANG). Therefore, the correct classification is MANG with high confidence.
2020-09-21 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.